Skip to main content
CDC Website

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
Support Types:
Discretionary Grants
Locations:
International
Maximum Amount:
$225,000
Fund ID:
PAR-24-029
Application Due Date:
Subjects:
Clinical Research
Data Analysis
Health Care Planning
HIV
HIV and AIDS Prevention
Medical Treatments and Therapies
Research
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
Persons with HIV/AIDS
Researchers
Last Updated:
Application Contact
Marina
Protopopova, Ph.D
Scientific/Research Contact- NIAID
301-761-7653
marina.protopopova@nih.gov
Technical Contact
Ann
Devine
Financial/Grants Management Contact -NIAID
United States
240-669-2988
adevine@niaid.nih.gov